The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial (Q83223892)
Jump to navigation
Jump to search
scientific article published on 01 May 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial |
scientific article published on 01 May 2006 |
Statements
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial (English)
Paul Emery
Arthur Kavanaugh
Roy Fleischmann
Anna Filipowicz-Sosnowska
Joy Schechtman
Leszek Szczepanski
Artur J Racewicz
Ronald F van Vollenhoven
Nicole F Li
Sunil Agarwal
Eva W Hessey
Timothy M Shaw
DANCER Study Group